1265 related articles for article (PubMed ID: 17443096)
1. Application of the main implantable cardioverter-defibrillator trials and the 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.
Proclemer A; Ghidina M
J Cardiovasc Med (Hagerstown); 2007 May; 8(5):320-3. PubMed ID: 17443096
[No Abstract] [Full Text] [Related]
2. [Indications for implantable cardioverter-defibrillator].
Tebbenjohanns J; Niehaus M; Korte T
Dtsch Med Wochenschr; 2002 Oct; 127(41):2120-4. PubMed ID: 12397558
[No Abstract] [Full Text] [Related]
3. Antiarrhythmic therapy for the prevention of sudden cardiac death.
Cairns J; Kerr C; Teo K
Can J Cardiol; 2000 Jun; 16 Suppl C():29C-33C. PubMed ID: 10887276
[No Abstract] [Full Text] [Related]
4. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia in patients with an implantable defibrillator warrants catheter ablation.
Kuck KH
Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):713-20; discussion 720. PubMed ID: 20009082
[No Abstract] [Full Text] [Related]
5. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment.
Technol Eval Cent Assess Program Exec Summ; 2010 Nov; 25(2):1-5. PubMed ID: 21638938
[No Abstract] [Full Text] [Related]
6. Primary prevention of sudden cardiac death: one step forwards and one step backwards.
Cain ME
Nat Clin Pract Cardiovasc Med; 2006 Mar; 3(3):115. PubMed ID: 16505838
[No Abstract] [Full Text] [Related]
7. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
Kusumoto FM; Calkins H; Boehmer J; Buxton AE; Chung MK; Gold MR; Hohnloser SH; Indik J; Lee R; Mehra MR; Menon V; Page RL; Shen WK; Slotwiner DJ; Stevenson LW; Varosy PD; Welikovitch L
Circulation; 2014 Jul; 130(1):94-125. PubMed ID: 24815500
[No Abstract] [Full Text] [Related]
8. Implantable cardioverter-defibrillator: present and future indications.
Block M; Scheld H; Breithardt G
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
[TBL] [Abstract][Full Text] [Related]
9. Should catheter ablation be the preferred therapy for reducing ICD shocks?: Ventricular tachycardia ablation versus drugs for preventing ICD shocks: role of adjuvant antiarrhythmic drug therapy.
Patel C; Yan GX; Kocovic D; Kowey PR
Circ Arrhythm Electrophysiol; 2009 Dec; 2(6):705-11; discussion 712. PubMed ID: 20009081
[No Abstract] [Full Text] [Related]
10. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
Ohnishi S; Kasanuki H
J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
[TBL] [Abstract][Full Text] [Related]
11. Implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death.
Akhtar M; Jazayeri MR; Sra JS; Dhala A; Deshpande S; Blanck Z; Axtell K
Cardiol Clin; 1993 Feb; 11(1):97-108. PubMed ID: 8435827
[TBL] [Abstract][Full Text] [Related]
12. Refining patient selection for primary prevention implantable cardioverter-defibrillator therapy: reeling in a net cast too widely.
Tung R; Swerdlow CD
Circulation; 2009 Sep; 120(10):825-7. PubMed ID: 19704090
[No Abstract] [Full Text] [Related]
13. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists.
Stevenson WG; Chaitman BR; Ellenbogen KA; Epstein AE; Gross WL; Hayes DL; Strickberger SA; Sweeney MO; ;
Circulation; 2004 Dec; 110(25):3866-9. PubMed ID: 15611390
[TBL] [Abstract][Full Text] [Related]
14. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).
; ; Zipes DP; Camm AJ; Borggrefe M; Buxton AE; Chaitman B; Fromer M; Gregoratos G; Klein G; Moss AJ; Myerburg RJ; Priori SG; Quinones MA; Roden DM; Silka MJ; Tracy C; Smith SC; Jacobs AK; Adams CD; Antman EM; Anderson JL; Hunt SA; Halperin JL; Nishimura R; Ornato JP; Page RL; Riegel B; Priori SG; Blanc JJ; Budaj A; Camm AJ; Dean V; Deckers JW; Despres C; Dickstein K; Lekakis J; McGregor K; Metra M; Morais J; Osterspey A; Tamargo JL; Zamorano JL; ; ;
J Am Coll Cardiol; 2006 Sep; 48(5):e247-346. PubMed ID: 16949478
[No Abstract] [Full Text] [Related]
15. [Implantable cardioverter-defibrillator: prevention of sudden cardiac death and impact on survival in patients with malignant ventricular arrhythmias].
Occhetta E; Magnani A; Francalacci G; Perucca A; Sarasso G; Piccinino C; Trevi G
Cardiologia; 1995 Jun; 40(6):419-25. PubMed ID: 8640855
[No Abstract] [Full Text] [Related]
16. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child.
Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC
Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320
[No Abstract] [Full Text] [Related]
17. [Implantable defibrillators--current status of guidelines. Recognized and possible indications--prerequisites].
Andresen D
Fortschr Med; 1996 Apr; 114(11):128-32. PubMed ID: 8682425
[TBL] [Abstract][Full Text] [Related]
18. [Automatic implantable defibrillators].
Licourt J; Orvin MA
Soins; 2003 Jan; Spec No 1(1):12-5. PubMed ID: 12621698
[No Abstract] [Full Text] [Related]
19. [Nursing care for automatic implantable defibrillators].
Pépin A; Samuel B; Kihel A
Soins; 2006; (702 Suppl):S3-5. PubMed ID: 16493932
[No Abstract] [Full Text] [Related]
20. Hypertrophic cardiomyopathy with midcavitary obstruction: another substrate for ventricular tachycardia?
Gerstenfeld EP
J Cardiovasc Electrophysiol; 2010 Sep; 21(9):1000-1. PubMed ID: 20487115
[No Abstract] [Full Text] [Related]
[Next] [New Search]
